Views & Analysis Is the NHS ready to use real-world evidence to treat cancer? Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?
News AbbVie, Gilead target sick hepatitis C patients in EU Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens.
Partner Content Partner Content HSJ Partnership Awards: new programme for inspirational orga... Recognition for private sector helping NHS
News Teva's Cinqaero to challenge Nucala after clearing NICE Discount swings NICE decision, drug will compete with GSK rival
News Alexion price cut opens up Strensiq to more patients Managed access scheme will control costs to NHS.
Views & Analysis Accelerating clinical research in Brazil Developments that promise to improve clinical research in Brazil.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
